ARTICLE | Company News
Protalix management update
October 6, 2014 7:00 AM UTC
Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX), Carmiel, Israel Business: Endocrine/Metabolic. Biosimilars, Biomanufacturing Hired: Moshe Manor as president and CEO, effective Nov. 2, forme...